EN DE
STOCK COMPARISON

Intuitive Surgical vs Anbio Biotechnology Class A: Fair Value & Quality

Both stocks run through our valuation models. Here is how Intuitive Surgical (ISRG) and Anbio Biotechnology Class A (NNNN) compare, as of Sep 24, 2026.

As of Sep 24, 2026, Fair Value Calculator sees Intuitive Surgical as the less overvalued of the two: Intuitive Surgical trades at $398 versus a fair value of $353 (-11%), while Anbio Biotechnology Class A trades at $6.06 versus $2.70 (-55%).
Intuitive Surgical
ISRG · USD · Health Care
-11%
upside to fair value
overvalued
Price$398
Fair Value$353
Quality73/100
Anbio Biotechnology Class A
NNNN · USD · Health Care
-55%
upside to fair value
overvalued
Price$6.06
Fair Value$2.70
Quality71/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green is the better side of a row, red the weaker one (for valuation multiples: lower = cheaper). Grey rows are for reference only and are not scored.

betterweakerfor reference, not scored

Intuitive SurgicalAnbio Biotechnology Class A
Valuation
48.3×P/E (TTM)40.4×
13.65×P/S (TTM)30.76×
8.10×P/B8.82×
36.3×EV/EBITDA39.7×
2.13×PEGn/a
−11.3%Fair value upside−55.4%
Profitability
31%Operating margin59%
1.22×EBIT margin trend (5Y)1.20×
17%Return on equity27%
10%Return on assets15%
Growth
23%Revenue growth (YoY)74%
17.4%Avg. growth/yr (3Y)-25.4%
18.2%Avg. growth/yr (5Y)n/a
+21.8%Value creation/yr+45.9%
Balance & size
99.2×Interest coverage (EBIT/interest)n/a
$144BMarket cap$266M
healthyGrowth qualityweak

Intuitive Surgical leads: 7 to 4 metric wins.

n/a = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Intuitive Surgicalof which business quality 71 · market factors 30 Anbio Biotechnology Class Aof which business quality 68 · market factors 0
ProfitabilityMargins and returns on capital today
66
70
Quality GrowthAre margins and returns improving?
66
76
CashflowEarnings quality: real cash, not paper profit
79
33
Fin. StrengthBalance sheet, leverage, solvency risk
82
97
InvestmentDisciplined investing over empire-building
37
33
Low VolatilityCalm price path (market factor)
39
0
MomentumPrice trend over the last 3–12 months (market factor)
27
0
52W MomentumDistance to the 52-week high (market factor)
24
1
Net IssuanceShare count: buybacks or dilution?
80
90

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyIntuitive SurgicalPrice $398Anbio Biotechnology Class APrice $6.06
DCF Models-45%below the price$220n/a
Earnings-Based-60%below the price$160-39%below the price$3.68
Dividend Discount-100%below the price$0.40n/a
Multiples-64%below the price$144-59%below the price$2.48
Asset-Based-92%below the price$33.72-92%below the price$0.46
Growth DCF-53%below the price$186n/a
Economic Profit-74%below the price$105-78%below the price$1.32
Growth Earnings-44%below the price$224-18%below the price$4.97
Minimum-100%below the price$0.40-92%below the price$0.46
Maximum-44%below the price$224-18%below the price$4.97
Median-62%below the price$152-59%below the price$2.48
Geometric mean-84%below the price$64.38-68%below the price$1.94

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Intuitive Surgical: 26 of 26 models see the stock below the current price.

Anbio Biotechnology Class A: 13 of 14 models see the stock below the current price.

Scenario ranges

From our cautious bear scenario to the optimistic bull scenario. The white tick is the current price (value above it), the green tick the fair value (value below it): if the price sits left of the fair value, there is room to rise.

Intuitive Surgical
Price $398
Fair Value $353
Bear $217Bull $583
Anbio Biotechnology Class A
Price $6.06
Fair Value $2.70
Bear $2.07Bull $3.33

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Intuitive Surgical · Health Care

Quality score73 · Top 25%
Fair value upside-11% · above median

Anbio Biotechnology Class A · Health Care

Quality score71 · Top 25%
Fair value upside-55% · below median

Bottom line

As of Sep 24, 2026, Fair Value Calculator sees Intuitive Surgical as the less overvalued of the two: Intuitive Surgical trades at $398 versus a fair value of $353 (-11%), while Anbio Biotechnology Class A trades at $6.06 versus $2.70 (-55%).

Intuitive Surgical has the higher quality score (73/100).

Open Intuitive Surgical live analysis →
Intuitive Surgical · Anbio Biotechnology Class A

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Intuitive Surgical

Microsoft vs NvidiaApple vs MicrosoftNvidia vs Taiwan Semiconductor ManufacturingApple vs Taiwan Semiconductor Manufacturing

Related to Anbio Biotechnology Class A

Alphabet Inc Class C vs Meta PlatformsCisco Systems vs NvidiaMicrosoft vs Taiwan Semiconductor ManufacturingApple vs Cisco Systems
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.